Whole blood miRNAs in relapsing MS patients treated with dimethyl fumarate in the phase 4 TREMEND trial. Elkjaer ML, Lohse RM, Burton M, Mendoza JP, et al. J Neuroimmunol 2023;381:578145.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Elkjaer ML, Lohse RM, Burton M, Mendoza JP, et al. Whole blood miRNAs in relapsing MS patients treated with dimethyl fumarate in the phase 4 TREMEND trial. J Neuroimmunol 2023;381:578145.
PMID: 37393851